Exelixis Inc (EXEL)
34.83
+0.18
(+0.52%)
USD |
NASDAQ |
Nov 21, 16:00
34.82
0.00 (0.00%)
After-Hours: 20:00
Exelixis Gross Profit Margin (Quarterly): 96.79% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 96.79% |
| June 30, 2024 | 97.23% |
| March 31, 2024 | 95.00% |
| December 31, 2023 | 95.46% |
| September 30, 2023 | 96.02% |
| June 30, 2023 | 96.23% |
| March 31, 2023 | 96.50% |
| December 31, 2022 | 96.24% |
| September 30, 2022 | 96.28% |
| June 30, 2022 | 96.79% |
| March 31, 2022 | 96.29% |
| December 31, 2021 | 97.14% |
| September 30, 2021 | 96.38% |
| June 30, 2021 | 96.14% |
| March 31, 2021 | 95.12% |
| December 31, 2020 | 96.65% |
| September 30, 2020 | 96.22% |
| June 30, 2020 | 96.45% |
| March 31, 2020 | 95.91% |
| December 31, 2019 | 95.62% |
| September 30, 2019 | 97.23% |
| June 30, 2019 | 96.86% |
| March 31, 2019 | 96.52% |
| December 31, 2018 | 96.78% |
| Date | Value |
|---|---|
| September 30, 2018 | 96.73% |
| June 30, 2018 | 96.78% |
| March 31, 2018 | 97.36% |
| December 31, 2017 | 96.51% |
| September 30, 2017 | 96.95% |
| June 30, 2017 | 96.96% |
| March 31, 2017 | 96.04% |
| December 31, 2016 | 97.61% |
| September 30, 2016 | 96.05% |
| June 30, 2016 | 95.70% |
| March 31, 2016 | 95.56% |
| December 31, 2015 | 89.71% |
| September 30, 2015 | 85.59% |
| June 30, 2015 | 91.42% |
| March 31, 2015 | 91.84% |
| December 31, 2014 | 90.70% |
| September 30, 2014 | 90.89% |
| June 30, 2014 | 92.73% |
| March 31, 2014 | 93.70% |
| December 31, 2013 | 93.95% |
| September 30, 2013 | 94.69% |
| June 30, 2013 | 97.60% |
| March 31, 2013 | 97.10% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
95.00%
Minimum
Mar 2024
97.23%
Maximum
Jun 2024
96.22%
Average
96.26%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 75.51% |
| ADMA Biologics Inc | 49.78% |
| Vericel Corp | 71.93% |
| Catalyst Pharmaceuticals Inc | 85.02% |
| Inovio Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.97% |
| Return on Assets | 16.15% |
| Return on Invested Capital | 20.97% |
| Profit Margin (Quarterly) | 21.87% |
| Operating Margin (Quarterly) | 34.82% |
| Return on Net Operating Assets | 57.32% |